Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • IPM grew 19 percent in...

IPM grew 19 percent in March, brands like Calpol, Augmentin observed highest growth: IQVIA

Farhat NasimWritten by Farhat Nasim Published On 2023-04-12T18:09:40+05:30  |  Updated On 12 April 2023 6:09 PM IST
IPM grew 19 percent in March, brands like Calpol, Augmentin observed highest growth: IQVIA
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: The Indian pharmaceutical market reported double-digit growth of 19 percent in the month of March 2023, according to IQVIA.

The Total Sales Audit (TSA) valued at Rs 200,507 crore with growth of 8 percent as of Moving Annual Turnover (MAT) March 2023 and Rs 17,107 crore for March month with growth of 19 percent was recorded. On the other hand, the Stockist Sales Audit (SSA) has been valued at Rs 169,705 crore with growth of 7 percent as of MAT March and Rs 14,414 crore for March month with growth of 19%.

As per the report, except Antidiabetic, all therapies exhibited double digit growth rate while Anti-infectives followed by Respiratory posted highest growth at 50 percent and 49 percent respectively. Last month, in February, Respiratory was ahead and registered at 55 percent, however, this month it slipped to second position after anti-infectives.

Performance of Derma and anti-diabetic showed single digit growth at 6 percent and 8 percent valued at Rs 1102 crore and Rs 1528 crore respectively.

Pharma firms including Abbott, Alkem, Intas, Torrent and Aristo have shown improvement in market share for the month of March as compared to February 2023. Meanwhile, Sun Pharma, Cipla, Mankind, Lupin, and Macleods reflected dip in market share for the current month as compared to previous month.

However, Sun Pharma held 7.4 percent of the market share among top ten firms that included Torrent Pharma, Abbott, Cipla, Mankind, Intas, Alkem, Lupin, Macleods and Aristo.

Among top ten firms for the month, Aristo posted highest growth of 36 percent valued at Rs 549 crore, followed by Alkem, Mankind, Macleods on Month level, while on MAT level, Intas has reflected the highest growth at 16 percent followed by Torrent and Alkem.

In the month of March (in comparison to Feb’23), among the top 25 companies Sun Pharma has maintained its top position in the IPM with a market share of 7.4 percent. Aristo improved by 2 ranks to reach 10th position. Emcure, Sanofi and Himalaya improved by 1 rank each to reach 14th, 20th and 25th positions respectively.

As per MAT March (in comparison to Feb’23), among the top 25 companies Sun Pharma has maintained its top position in the IPM with a market share of 8%. All companies maintained their ranks for MAT Mar’23, except Aristo improved 1 rank to reach 11th position.

Augmentin identified itself as the topmost brand with 77 crores of sales. Among top 10 brands for the month, highest growth was observed by Calpol, Monocef and Augmentin with a growth of 106%, 72% & 45% each respectively.

Mixtard, Glycomet-GP, Foracort, Lantus, Clavam, Pan and Thyronorm were registered as the other brands in the top ten list for March.

Star brands of the month

Among the Top 25 products as per Mar’23 Month (in comparison to Feb’23 Month), Augmentin maintained its number one position at month level with a growth of 45%. Glycomet-GP gained 1 rank to secure 3rd position, respectively.

Lantus gained 2 ranks to secure 6th position with a growth of -3%. While, Monocef gained 4 ranks to secure 5th position with a growth of 72%. Calpol, Pan gained 5 ranks to secure 8th, 9th position respectively with a growth of 106%, 17% each respectively.

Liv-52 gained 6 ranks to secure 15th position with a growth of 9%, and T-Bact gained 17 ranks to secure 23rd position with a growth of 27%.

Talking about the trends, Indian companies registered growth of 20% whereas MNC’s registered a growth of 14% for March. Further, Acute showed growth of 22% whereas Chronic showed growth of 15% for the month.

An insight of top therapy trends, exhibited highest growth of 24% by Cilnidipine in cardiac. In Anti-Infective, Azithromycin Oral Solids posted 123% growth which is highest amongst top therapies.

The top contributing subgroup in gastrointestinal (GI) therapy with value of around 127 crore growing at 15% was grabbed by Pantopr. + Domperid. In anti diabetic, Fast Acting subgroup posted highest growth of 16%, while in Vibrating Mesh Nebulizers (VMN) therapy, food supplements was the top contributing subgroup with 168 crore of sales posted growth of 14%.

In Respiratory market, cough prep was observed to be top contributing one with 282 crore of sales and posted growth of 123%. While, in pain market, paracetamol oral solids, liquids and inj contributed ~ 182 crore of sales with 103%, 67% and 47% growth, respectively.

Emollients protectives registered highest sales of 129 crore in derma market with 16% growth while the highest growth of 23% was observed in Mupirocin. In Neuro therapy, levetiracetam was the top valued subgroup with 82 crores of sales and 10% growth.

In Gynaec therapy, conv iron solids, liquids and inj. together have contributed ~274 crore of sales to the entire therapy. Amongst the top Gynae therapies, Dydrogesterone posted highest growth of 40%.

Key changes

Among the top 50 brands of the industry, PTR changes reflected in SKUs of the following brands: Duphaston; Udiliv; Augmentin; Azithral; Azithral; Clavam; Ecosprin-Av; Glycomet-Gp; Glycomet-Gp; Levipil; Levipil; Manforce; Manforce; Manforce; Moxikind-Cv; Pan; Thyronorm; Thyronorm; Thyronorm; Thyronorm; Thyronorm; Vertin; Augmentin; Betadine; Rantac.

2 Corporates and Labs were introduced in March dataset, while 4 brand transfers were registered.

Torrent PharmaAbbottCiplaMankindIntasAlkemLupinMacleodsAristosun pharmaaugmentinCalpolMonocefMixtardGlycomet GPForacortLantusClavamPanThyronormpharmapharma marketipmindian pharma marketmarchiqviaindian pharma news
Farhat Nasim
Farhat Nasim

    Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

    U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or...

    Aspirin in Primary Prevention: Prudent Guideline-Based Approach

    Aspirin in Primary Prevention: Prudent Guideline-Based Approach

    Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

    Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

    Environmental Impact on Seborrheic Dermatitis, Tinea versicolor and Dandruff: The Role of Selenium Sulfide in Seborrheic Dermatitis Management

    Environmental Impact on Seborrheic Dermatitis, Tinea versicolor and Dandruff: The Role of Selenium...

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in stage IV metastatic gallbladder cancer - Dr AVS Suresh

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in stage IV metastatic...

    View All

    Journal Club Today

    Sleeping 2 Extra Hours on Weekends May Calm Teen Anxiety: Study Suggests

    Sleeping 2 Extra Hours on Weekends May Calm Teen Anxiety: Study Suggests

    View All

    Health News Today

    Health Bulletin 16/June/2025

    Health Bulletin 16/June/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok